APA (7th ed.) Citation

Blennow, K., Dubois, B., Fagan, A. M., Lewczuk, P., de Leon, M. J., & Hampel, H. (2015). Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease. Alzheimer's & dementia, 11(1), 58-69. https://doi.org/10.1016/j.jalz.2014.02.004

Chicago Style (17th ed.) Citation

Blennow, Kaj, Bruno Dubois, Anne M. Fagan, Piotr Lewczuk, Mony J. de Leon, and Harald Hampel. "Clinical Utility of Cerebrospinal Fluid Biomarkers in the Diagnosis of Early Alzheimer's Disease." Alzheimer's & Dementia 11, no. 1 (2015): 58-69. https://doi.org/10.1016/j.jalz.2014.02.004.

MLA (9th ed.) Citation

Blennow, Kaj, et al. "Clinical Utility of Cerebrospinal Fluid Biomarkers in the Diagnosis of Early Alzheimer's Disease." Alzheimer's & Dementia, vol. 11, no. 1, 2015, pp. 58-69, https://doi.org/10.1016/j.jalz.2014.02.004.